Benvenuti sul sito web di Farmacovigilanza

Feed rss AIFA: Notizia

16/10/2026

Aggiornamento "Diario di bordo sulla Trasparenza"

Ultime notizie

01/06/2026

Sicurezza delle terapie avanzate per la malattia di Chron

Biblioteca Virtuale per la Salute – Piemonte

06/10/2026

Newsletter Disuguaglianze di salute n.57

Agendas and minutes

16/10/2026

Agenda - Medicine Shortages SPOC Working Party meeting 13-14 October 2026

Consumer Updates RSS Feed

05/10/2026

Advisory Committees Give FDA Critical Advice and the Public a Voice

Regulatory and procedural guidelines (human and veterinary)

09/10/2026

Questions and answers on the PIP compliance verification procedure at EMA, and on paediatric rewards

Scientific guidelines (human and veterinary)

16/10/2026

Concept paper on clinical trials in recipients of kidney transplantation

Paediatric investigation plans

14/10/2026

Opinion/decision on a Paediatric investigation plan (PIP): Opdualag, nivolumab,relatlimab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: P/0169/2024

Orphan designations

07/10/2026

Orphan designation: somapacitan Treatment of growth hormone deficiency, 24/08/2018 Withdrawn

New medicines and opinions: human

16/10/2026

Human medicines European public assessment report (EPAR): Yuviwel, Navepegritide, Status: Opinion

MedWatch Safety Alerts RSS Feed

15/10/2026

Early Alert: Transcatheter Mitral Valve Delivery System Issue from Edwards Lifesciences

What's New: Drugs RSS Feed

15/10/2026

What's New Related to Drugs

FDA Drug Safety Podcasts

02/01/2025

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis